Product NDC: | 42291-382 |
Proprietary Name: | Levetiracetam |
Non Proprietary Name: | levetiracetam |
Active Ingredient(s): | 750 mg/1 & nbsp; levetiracetam |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42291-382 |
Labeler Name: | AvKARE, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078106 |
Marketing Category: | ANDA |
Start Marketing Date: | 20051228 |
Package NDC: | 42291-382-18 |
Package Description: | 180 TABLET in 1 BOTTLE (42291-382-18) |
NDC Code | 42291-382-18 |
Proprietary Name | Levetiracetam |
Package Description | 180 TABLET in 1 BOTTLE (42291-382-18) |
Product NDC | 42291-382 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levetiracetam |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20051228 |
Marketing Category Name | ANDA |
Labeler Name | AvKARE, Inc. |
Substance Name | LEVETIRACETAM |
Strength Number | 750 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |